Extracorporeal Shock Wave Technology (ESWT)

Extracorporeal Shockwave Therapy (ESWT) is a noninvasive treatment which involves passing high-frequency  acoustic waves through the skin and into muscle, bone, or tissue for  therapeutic effect. Typically, shockwave therapy is used to promote  accelerated tissue repair and cell growth, analgesia and mobility  restoration.

The treatment has been commonly used in treating musculoskeletal issues since the 1980s, and its advantages include:

• No pain.
• No down-time.
• Drug-free.
• Quick results.
• No known side effects.

Since then, large amounts of research has taken place on the  dose-dependent effects of shockwave therapy of various tissues from skin  and muscles to tendons and bone. Researchers discovered that low doses  were more destructive (used for treatments like breaking down kidney  stones) whereas high doses were more regenerative, leading to the  regeneration of soft tissues and even healing bones.

Shockwave therapy for ED uses about one-tenth of the energy used for kidney stones to avoid damaging any tissue in the penis.

Erectile dysfunction (ED) can have many root causes, however in 90% of men with ED,  it is an indication of an underlying medical issue, most commonly  cardiovascular disease or diabetes. Disorders like these often restrict  blood flow to the penis, which is what medications like sildenafil  (Viagra) and tadalafil (Cialis) try to correct.

The issue with taking these  medications to improve blood flow however, is that they can’t be taken  by those with certain conditions including high blood pressure, a past  heart attack, liver issues, Peyronie’s disease,  and many more. They also temporarily cover up the issue without  treating the root cause, which in many cases could lead to a worsening  of underlying conditions.

The waves of pressure generated by  focused shockwave therapy devices improve blood flow by dissolving  plaque buildup in the penis and promoting the formation of new blood  vessels (angiogenesis), helping to treat the root cause and provide  lasting effects in 75% of patients.